6533b82efe1ef96bd1293ce7
RESEARCH PRODUCT
Rapid Regression of Exudative Maculopathy in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis Syndrome after Intravitreal Ranibizumab
Roberto Gallego-pinazoManuel Díaz-llopisJavier NavarreteDavid SalomCristina Marín-lambíessubject
medicine.medical_specialtyExudative maculopathyRapid regressiongenetic structuresbusiness.industryRetinal vasculitisPublished online: August 2012medicine.diseaseeye diseasesOphthalmologylcsh:Ophthalmologylcsh:RE1-994OphthalmologyRanibizumabmedicineIdiopathic retinitisIdiopathic retinitis vasculitis aneurysms and neuroretinitis syndromeRetinal Vascular DisorderRanibizumabIntravitreal ranibizumabbusinessVasculitisExudative maculopathymedicine.drugdescription
The idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome is a rare retinal vascular disorder characterized by multiple leaking aneurysmal dilations, retinal vasculitis, neuroretinitis and peripheral vascular ischemia. Visual loss mainly occurs due to the development of retinal neovascularization and/or exudative maculopathy. Although the treatment of choice has not yet been established, retinal photocoagulation seems to be the best option to control the disease and to prevent its progression. Herein, we report a case of idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome with both retinal neovascularization and macular exudation successfully managed with intravitreal ranibizumab (Lucentis®) as adjunctive therapy to retinal photocoagulation.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2012-08-01 | Case Reports in Ophthalmology |